Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0001628280-26-009803

Chief Financial Officer sold 8,149 shares at $3.84 ($31,292)

  • Chief Financial Officer acquired 27,584 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kelly John Alexander Chief Financial Officer 2026-02-17 Option exercise 10b5-1 +27,584 134,032 D
Kelly John Alexander Chief Financial Officer 2026-02-18 Sale 10b5-1 −8,149 $3.84 $31,292 125,883 D
Derivatives
Kelly John Alexander Chief Financial Officer 2026-02-17 Option exercise · Restricted Stock Units 10b5-1 −27,584 55,166 D
Open-market sales · 8,149 sh · avg $3.84 · $31,292
Loading xslF345X05/wk-form4_1771536658.xml…